Background-Human induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs) are a promising source of cells for regenerating myocardium. However, several issues, especially the large-scale preparation of hiPS-CMs and elimination of undifferentiated iPS cells, must be resolved before hiPS cells can be used clinically. The cell-sheet technique is one of the useful methods for transplanting large numbers of cells. We hypothesized that hiPS-CM-sheet transplantation would be feasible, safe, and therapeutically effective for the treatment of ischemic cardiomyopathy.
T he myocardium has limited regenerative capacity, and loss of myocardium due to myocardial infarction therefore leads to heart failure. Despite remarkable recent progress in medical and surgical treatments for heart failure, end-stage heart failure remains a leading cause of morbidity and mortality. 1 Therefore, the myocardium is one of the most important targets in regenerative medicine. Cell therapy has been introduced as a new treatment for heart failure. Clinical trials using bone marrow cells and myoblasts are underway; although these cells improve cardiac performance, chiefly through paracrine cytokine effects, they show limited differentiation into cardiomyocytes. 2 Induced pluripotent stem (iPS) cells were first generated by nuclear reprogramming of mouse fibroblasts in 2006, 3 and human iPS (hiPS) cells were established in 2007 by the transduction of defined factors. 4, 5 The production of hiPS cells poses fewer legal and ethical issues than does the generation of human embryonic stem (ES) cells. In addition, recent studies have demonstrated methods for the highly efficient production from hiPS cells of cardiomyocytes with typical electrophysiological function and pharmacological responsiveness. 6, 7 Human iPS cells represent an unlimited source of cardiomyocytes because of their great potential for differentiation and are therefore one of the most promising sources of cells for cardiac regenerative therapy. 8, 9 Nevertheless, many important problems, especially the large-scale preparation of cardiomyocytes by differentiation of iPS cells and the elimination of undifferentiated iPS cells to avoid teratoma formation, must be addressed before hiPS cells can be used clinically. 8, 9 The recently developed scaffoldless tissue engineering technique of cell-sheet engineering is applicable to myocar-dial regeneration therapy. 10 In contrast to the needle injection technique, the cell-sheet technique can deliver a large number of cells to damaged myocardium without the loss of transplanted cells or injury to the host myocardium. We have previously reported that use of the cell-sheet technique with autologous skeletal myoblasts improves cardiac function in small and large animal models of ischemic cardiomyopathy. 11, 12 We hypothesized that hiPS-derived cardiomyocyte (hiPS-CM)-sheet transplantation would be therapeutically effective in the context of ischemic cardiomyopathy. In this study, we examined the following aspects of this procedure: stable in vitro culture of a large number of cardiomyocytes by differentiation of hiPS cells, generation of hiPS-CM sheets for clinical applications using temperature-responsive dishes, survival of hiPS-CM sheets in the myocardium of a large animal, and the direct contribution of these sheets to the improvement of cardiac performance by structural and electromechanical integration into the recipient myocardium, without teratoma formation, in a porcine ischemic cardiomyopathy model.
Materials and Methods
Animal care complied with the "Guide for the Care and Use of Laboratory Animals" (National Institutes of Health publication No. 85-23, revised 1996) . Experimental protocols were approved by the Ethics Review Committee for Animal Experimentation of Osaka University Graduate School of Medicine.
Culture, Differentiation, and Purification of hiPS Cells and Collection of Conditioned Medium
The hiPS cell line 201B7 that was generated using the 4 transcription factors Oct4, Sox2, Klf4, and c-Myc (a generous gift from Professor Yamanaka, Kyoto University, Kyoto, Japan) was used in this study. 4 The hiPS cells were cultured on Matrigel (BD Bioscience)-coated dishes in mTeSR1 medium (Stem Cell Technologies).
Human iPS cells were then dissociated using StemPro Accutase Cell Dissociation Reagent (Invitrogen), transferred to Corning ultralow-attachment surface culture dishes (Sigma-Aldrich) at a density of 50 000 cells/mL in mTeSR1 with Y-27632 (Wako), and cultured for 4 days to allow them to form embryoid bodies. The embryoid bodies were replated with differentiation medium (DMEM-F12; Invitrogen) containing 20% fetal bovine serum, 100 mol/L nonessential amino acids (Invitrogen), 50 U/mL penicillin, 50 mg/mL streptomycin (Invitrogen), and 5.5 mmol/L 2-mercaptoethanol (Invitrogen) and supplemented with 100 ng/mL Wnt3a (R&D Systems) and 100 ng/mL R-Spondin-1 (Stem RD) and cultured for 2 days. The culture medium was then replaced with differentiation medium without the supplemental factors for 2 days and then changed to differentiation medium supplemented with 100 ng/mL Dkk1 (R&D Systems) for 2 days. On Day 10, the embryoid bodies were plated on gelatin-coated dishes in differentiation medium, which was refreshed every 2 days.
The culture medium was subsequently replaced with no-glucose Dulbecco modified Eagle medium (Invitrogen) with 1 mmol/L lactic acid (Wako; F. Hattori and K. Fukuda. WO2007/088874; PCT/ JP2007/051563, 2007) on Day 20 and changed to Dulbecco modified Eagle medium/10% fetal bovine serum the next day. On Day 25, the culture medium was again replaced with no-glucose Dulbecco modified Eagle medium with 1 mmol/L lactic acid and changed to Dulbecco modified Eagle medium/10% fetal bovine serum the next day; this procedure eventually generated pure hiPS-CM. The hiPSCMs were then labeled with a red fluorescent marker (CellTracker Red CMTPX; Invitrogen) as previously described. 13 Fetal bovine serum-free Dulbecco modified Eagle medium media were conditioned by hiPS-CMs for 48 hours after the completion of our differentiation and purification protocols. A total of 48 cytokines and growth factors were measured by the Bio-Plex human cytokine assay (Bio-Rad) for in vitro screening.
Preparation of hiPS Cell-Derived Cardiomyocyte Sheets
The hiPS-CMs were detached using StemPro Accutase Cell Dissociation Reagent and seeded onto 6-cm UpCell dishes (CellSeed). The next day, the dish was incubated at room temperature, which caused the cells to detach spontaneously to form scaffold-free hiPS-CM sheets.
Generation of the Porcine Chronic Myocardial Infarction Model and hiPS-CM Sheet Transplantation
A chronic myocardial infarction model was generated by placement of an ameroid constrictor (COR-2.50-SS; Research Instruments) around the left anterior descending coronary artery in female minipigs (Japan Farm) weighing 20 to 25 kg 14 ( Figure 1 ). Four weeks after myocardial infarction induction, transplantation of hiPS-CM sheets was performed through median sternotomy under general anesthesia. All animals were immunosuppressed with daily intake of tacrolimus (0.6 mg/kg; Astellas) from 5 days before transplantation until euthanasia. The minipigs were randomly divided into 2 treatment groups, either hiPS-CM sheet transplantation (iPS group) or sham operation (nϭ6 each).
Standard and 2-Dimensional Speckle-Tracking Echocardiography
Transthoracic echocardiography was performed under general anesthesia using a 5.0-MHz transducer (Aplio Artida). The left ventricular (LV) end-diastolic and end-systolic diameters were measured, whereas the LV end-diastolic and end-systolic volumes (LVEDV and LVESV, respectively) were calculated from the Teichholz formula. 15 The LV ejection fraction (LVEF) was calculated from the following formula: LVEF (%)ϭ100ϫ(LVEDVϪLVESV)/(LVEDV).
Two-dimensional speckle-tracking echocardiography analysis was performed using the customized 2-dimensional speckle-tracking echocardiography software for the Toshiba system (2D Wall Motion Tracking). Regional cardiac function was evaluated using radial strain values obtained from the midshort-axis plane and expressed as a percentage. 
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Cardiac CT Scan
Electrocardiography-gated multislice CT was performed in the supine position with a 16-slice multislice CT scanner (Somatron Emotion 16; Siemens) during end-expiratory breathhold under general anesthesia. Multislice CT was performed after intravenous injection of 90 mL of nonionic contrast medium (Iomeprol; Bracco Imaging). Axial images were reconstructed using the scanner software. All images were analyzed on a workstation (AZE; Virtual Pl Lexus 64). LVEDV and LVESV were obtained from the workstation and LVEF was calculated using the formula described previously.
Holter Electrocardiography
Holter electrocardiography was performed for 24 hours in both groups (nϭ6 each). The arrhythmogenesis associated with hiPS-CM sheet transplantation was evaluated based on the number of premature ventricular contractions.
Histology, Immunohistolabeling, and Fluorescence In Situ Hybridization
Dissociated cultured cells were fixed in 4% paraformaldehyde. Primary antibodies included anticardiac troponin T (cTNT; Abcam), anti-Nkx2.5 (Santa Cruz Biotechnology), anti-␣-actinin (Sigma-Aldrich), antihuman CD31 (BD Bioscience), antihuman CD34 (BD Bioscience) and antivimentin (BD Bioscience) visualized by fluorescent-conjugated secondary antibodies such as AlexaFluor488 goat antirabbit IgG, AlexaFluor488 goat antimouse IgG, and AlexaFluor488 donkey antigoat IgG (Invitrogen) with counterstaining by 4Ј6-diamidino-2-phenylindole (Dojindo) and assessed by fluorescence microscopy. Images of the samples were acquired with a Biorevo BZ-9000 (Keyence). Positivity of the cardiomyocytespecific markers or other lineage markers in the cultured cells was determined from the acquired images by using computer-based cell counting with the Dynamic Cell Count BZ-H1CE software (Keyence). The excised heart specimen was fixed with either 10% buffered formalin or 4% paraformaldehyde for frozen sections. Picrosirius red or periodic acid-Schiff stains were used to assess interstitial fibrosis or cardiomyocyte hypertrophy, respectively. To evaluate neovascularization in the peri-infarct area, immunolabeling with antihuman von Willebrand factor antibody (Dako) was done. The frozen sections were immunolabeled by the primary antibodies such as anticTNT (Abcam) and antislow myosin heavy chain (Sigma-Aldrich) antibodies, visualized by AlexaFluor488 goat antimouse IgG (Invitrogen), counterstained by 4Ј,6-diamidino-2-phenylindole, and assessed by fluorescence microscopy or confocal laser microscopy.
The hiPS-CMs at 8 weeks after transplantation were detected by fluorescent in situ hybridization using a human specific genomic probe labeled by Cy3 (Chromosome Science Labs). The samples were double-stained with other antibodies described previously and counterstained with 4Ј,6-diamidino-2-phenylindole.
Real-Time Polymerase Chain Reaction
Total RNA was extracted from cardiac tissue and reverse transcribed using TaqMan reverse transcription reagents (Applied Biosystems), and real-time polymerase chain reaction was performed with the ABI PRISM 7700 (Applied Biosystems) system using pig-specific primers for vascular endothelial growth factor and basic fibroblast growth factor. The average copy number of gene transcripts was normalized to that of glyceraldehyde-3-phosphate dehydrogenase for each sample.
Statistical Analysis
JMP software (JMP7.01; SAS Institute Inc) was used for all statistical analyses. Continuous values are expressed as the meanϮSD. Within-group differences were compared with the Wilcoxon signed-rank test and between-group differences with the Wilcoxon-Mann-Whitney U test because the sample sizes are too small (just nϭ6 in each group and nϭ6 pairs) to allow checking of the assumptions of the unpaired and paired t tests, respectively. A probability value Ͻ0.05 was considered statistically significant.
Results

Generation of Highly Purified hiPS-CM Sheets
Cardiomyogenic differentiation of hiPS cells was induced by treatment of the embryoid bodies formed from cultured hiPS cells with Wnt3a and R-Spondin-1. Subsequently, the differentiated hiPS cells were purified by culture in glucose-free medium to yield hiPS-CMs. The hiPS-CMs were highly positive for the cardiomyocyte-specific markers ␣-actinin (89.7%Ϯ3.8%), cTNT (87.4%Ϯ4.2%), and Nkx2.5 (84.2%Ϯ 4.3%), as assessed by immunohistolabeling (Figure 2A-D) . In addition, the hiPSCMs included a small population of cells expressing vascular endothelial or endothelial progenitor cell-specific markers such as CD31 (2.9%Ϯ3.0%) and CD34 (1.6%Ϯ1.4%; Figures 2A,  2E , and 2F). These cells also included a small population of vimentin-positive cells (2.4%Ϯ1.0%), which is a marker of fibroblast or smooth muscle cells (Figures 2A and 2G) .
Serum-free conditioned media from hiPS-CMs were screened for the secreted factors by using enzyme-linked immunosorbent assay ( Figure 2H-I ). The media contained high concentrations of various factors such as hepatocyte growth factor (HGF), stromal cell-derived factor (SDF), interluekin 6, leukemia inhibitory factor (LIF), macrophage migration inhibitory factor (MIF), and monocyte chemoattractant protein-1.
Subsequently, culture in the thermoresponsive dishes yielded round-shaped scaffold-free hiPS-CM sheets ( Figure 2J ). Hematoxylin & eosin-stained cross-sections of the sheet showed a 30-to 50-m-thick regular structure with abundant extracellular matrix ( Figure 2K ). Immunohistolabeling showed that the cytoplasm of most of the cells in the hiPS-CM sheets was homogeneously positive for cTNT ( Figure 2L ).
Feasibility and Safety of hiPS-CM Sheet Transplantation Into the Chronic Myocardial Infarction Heart
Transplantation of 8 hiPS-CM sheets was successfully performed through median sternotomy under general anesthesia in 6 immunosuppressed minipigs with LVEF values of 35% to 45% due to induced chronic myocardial infarction. There was no mortality related to the procedure or otherwise before the planned euthanasia. Twenty-four-hour electrocardiography monitoring only rarely identified ventricular arrhythmias in either group before the planned euthanasia (data not shown). In addition, no teratomas were formed in the heart or other thoracic organs within the 8 weeks after the transplantation of the hiPS-CM sheets (data not shown).
Global Cardiac Functional Recovery After hiPS-CM-Sheet Transplantation
Serial standard transthoracic echocardiography was performed before and 4 and 8 weeks after the cell-sheet transplantation or sham surgery. The baseline LV end-diastolic diameter, LV end-systolic diameter, and LVEF did not differ significantly between the 2 groups. The sham-operated pigs showed nonsignificant upward trends in LV end-diastolic diameter and LV end-systolic diameter and a downward trend in LVEF between 4 and 8 weeks after surgery ( Figure 3A-C Figure 4A ). LVEDV and LVESV were significantly smaller in the iPS group than in the sham group (57.1Ϯ7.5 mL versus 76.1Ϯ4.1 mL, PϽ0.05, and 28.3Ϯ6.0 mL versus 45.3Ϯ3.0 mL, PϽ0.05, respectively; Figure 4B -C).
Recovery of Regional LV Wall Motion After hiPS-CM Sheet Transplantation
Serial speckle-tracking echocardiography was performed to compare the strain values at baseline and 4 weeks after the treatment. Radial strain was measured from the midshort-axis plane to evaluate regional wall motion ( Figure 5B-C) . In the sham group, the radial strain levels in the infarct, the border, and the remote area had not changed significantly after 4 weeks relative to the baseline values. In contrast, in the iPS group, the radial strain in the border area was significantly greater after 4 weeks than at baseline (10.35%Ϯ4.17% versus 15.22%Ϯ1.66%, PϽ0.05), whereas the radial strain levels in the infarct and the remote area had not changed significantly.
Pathological Hypertrophy, Interstitial Fibrosis, and Vascular Density
The pathological cardiomyocyte hypertrophy, interstitial fibrosis, and vascular density 8 weeks after the treatment were assessed semiquantitatively by periodic acid-Schiff staining, picrosirius red staining, and immunohistochemistry for von Willebrand factor, respectively ( Figure 6 ). The diameters of the cardiomyocytes in the remote area were significantly smaller in the iPS group than in the sham group. There was consistently significantly less accumulation of interstitial fibrosis in the remote area in the iPS group than in the sham group. In addition, the vascular density in the border area was significantly greater in the iPS group than in the sham group.
Upregulation of Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Expression in the Border Area After Treatment
The expression levels of growth factors that are expressed in the myocardium and are potentially related to neovascular- ization were quantified by real-time polymerase chain reaction 8 weeks after the treatment. The expression levels of vascular endothelial growth factor and basic fibroblast growth factor in the border area were significantly greater in the iPS group than in the sham group (Figure 7 ).
Phenotypic Fate of the Transplanted iPS-CMs in the Heart
The hiPS-CMs were labeled in vitro with a red fluorescent marker before transplantation. The labeled cells were identified on the surface of the heart 2 weeks after transplantation. Some of these cells were positive for slow myosin heavy chain ( Figure 8A-D) . Because the labeled cells could no longer be identified by 8 weeks after transplantation, the presence of the transplanted cells was assessed by fluorescence in situ hybridization using a human-specific genomic probe 8 weeks after transplantation. A small number of human genome-positive cells that expressed slow myosin heavy chain remained present in the infarct area ( Figure  8E -G).
Discussion
The major findings of this study were as follows: (1) the newly developed culture system for hiPS cells successfully yielded approximately 2.5ϫ10 7 highly pure hiPS-CMs, and hiPS-CM sheets could be made from these high pure hiPSCMs using temperature-responsive dishes; (2) the hiPS-CM sheets survived in damaged myocardium in the short term and improved cardiac function in a porcine ischemic cardiomyopathy model, chiefly through the paracrine effects of cytokines. Histological analysis indicated that transplantation of hiPS sheets attenuated left ventricular remodeling and increased neovascularization; and (3) hiPS-derived cardiomyocytes could still be detected 8 weeks after transplantation, but the number of hiPS-CMs that survived long term was very small. No teratoma formation was observed in animals that received hiPS-CM sheets.
The optimal number of cells for clinical use of cardiac regeneration therapy remains unknown. Implantation of approximately 10 8 to 10 9 cells was shown to produce cardiac improvement in previous clinical trials using bone marrowderived cells. 16 Given these results, it may be necessary to transplant almost this number of hiPS-CMs into impaired myocardium to improve cardiac function in a clinical setting. It is challenging to obtain large numbers of hiPS-CMs at high purity because clinical application of hiPS cells requires 3 steps (ie, proliferation, differentiation, and purification). In the present study, we obtained approximately 2.5ϫ10 7 hiPSCMs after differentiation and purification of hiPS cells. One advantage of our culture system for hiPS cells its simplicity, because it involves only supplementation with cytokines for differentiation and culture in glucose-free medium for purification. Our culture system might be able to yield higher numbers of hiPS-CMs and could, possibly, be expanded to a clinically useful scale. Moreover, a previous study evaluating the propensity of secondary neurospheres generated from iPS cells to form teratomas found a significant correlation between the teratoma diameter and the proportion of undifferentiated cells in the secondary neurospheres. 17 Importantly, no teratoma formation was detected in the current experiment, which could be because our purification method limited the number of undifferentiated iPS cells in the hiPS-CMs.
Structural connection and electromechanical integration have been considered to be the mechanisms of functional recovery of the impaired myocardium after ES cell-derived cardiomyocyte transplantation. 18, 19 We therefore predicted that the hiPS-CMs would connect structurally and electromechanically with the host myocardium, as seen for ES cell-derived cardiomyocytes. However, although functional cardiac recovery was observed after hiPS-CM-sheet transplantation, only a few transplanted cells were persistently present. It has been shown that the therapeutic effects of stem cell therapy can result from paracrine or direct effects. Paracrine effects have been considered as the major mechanisms responsible for the therapeutic efficacy of cell therapy with somatic tissuederived stem or progenitor cells. These effects classically refer to the ability of transplanted cells to extracellularly D (iPS) . A, In the sham group, the radial strain values of all areas did not differ significantly between the baseline and 4 weeks after the sham operation. C, In the iPS group, the radial strain value of the border area of the infarct was significantly greater 4 weeks after treatment than at baseline. The radial strain values of the other areas relative to the infarct did not differ significantly before and after hiPS-CM-sheet transplantation. †PϽ0.05 versus baseline. iPS indicates induced pluripotent stem cells; hiPS-CM, human induced pluripotent stem cell-derived cardiomyocyte.
release various cardioprotective factors into the damaged cardiac tissue to directly enhance reverse LV remodeling. In contrast, recent reports have suggested that cell transplantation upregulates various cardioprotective factors native to the cardiac tissue through "crosstalk" between the transplanted cells and the native cardiac tissue. 2, 20 In addition, another report has shown that paracrine effects of human cardiosphere-derived cells, which are capable of directed cardiac regeneration in vivo, play important roles in improving infarcted myocardium. 21 In our study, we observed that several factors, which were reportedly involved in cardiac repair, 20 were secreted by hiPS-CMs during in vitro screening. Consequently, cardiomyocyte hypertrophy and interstitial fibrosis were significantly attenuated in the infarct-remote area after cell sheet transplantation. In addition, capillary density was increased in the infarct border area associated with the upregulation of vascular endothelial growth factor and basic fibroblast growth factor after cell sheet transplantation. Speckle-tracking echocardiography showed that the regional function in the corresponding area was preserved after cell sheet transplantation as compared with that after a sham operation, in which the regional function progressively deteriorated. This suggests that ischemia-related hibernation in the infarct border myocardium might have recovered by increased blood flow because of angiogenesis. These findings suggest that in our study, paracrine effects are the major mechanisms underlying the functional improvement after hiPS-CM-sheet implantation. In contrast, only a small fraction of the transplanted cells differentiated into cardiac lineage, as assessed by fluorescence in situ hybridization analysis, which clearly distinguished cells of human origin from porcine cardiac tissue. This finding suggests that direct effects were not a major contributing mechanism responsible for the functional benefits observed in this study. Therefore, it will be important to develop additive treatment to enhance survival, differentiation, and integration of the transplanted cells into the cardiac tissue.
Histological analysis revealed that most of the implanted hiPS-CMs disappeared after implantation, indicating poor engraftment of the hiPS-CMs into the impaired myocardium. In our study, hiPS-CMs secreted multiple angiogenic factors or their inducers, and the hiPS-CMs included small populations of CD31-or CD34-positive cells. These findings indicate that the hiPS-CM sheets have angiogenic potential, which might result in the generation of new vascular networks between the hiPS-CM sheets and the host cardiac tissue. A previous report has shown that the prompt formation of a vascular network between the cell sheet and the surrounding host tissue can sufficiently supply blood and oxygen to the transplanted cell sheet to survive and function in the host tissue. 22 However, in the present study, the host myocardium persistently experienced low blood supply due to coronary artery occlusion, which can interfere with the formation of a new vascular network between the cardiac tissue and the transplanted hiPS-CM sheets, possibly leading to poor survival and differentiation of the transplanted cells in the heart. Poor engraftment has been shown after experimental transplantation of human ES cell-derived cardiomyocytes through simple injection into the infarcted myocardium; treatment with several factors that block cell death pathways improved the engraftment of transplanted ES cell-derived cardiomyocytes. 23 We recently established a new method of cell protection by gene transfection 24 and a novel cell delivery system using the omentum, 25 which can enhance the therapeutic effects of cell therapy. Additional methods of prolonging cell survival after implantation might be necessary to improve the engraftment rate and thus obtain long-standing therapeutic effects of the hiPS-CM sheet from not only paracrine factors, but also direct contributions to the host heart.
Successful regeneration therapy using human pluripotent stem cells requires that the stem cells or their derivatives remain in the recipient myocardium long term. Unless the cell transplantation is autogeneic, the cells will inevitably be rejected by the immune system. Future clinical applications of hiPS cells for regeneration therapy may involve allogeneic and HLA type-matched transplantations, because some acute injuries such as myocardial infarction, stroke, or spinal cord trauma are targeted for regeneration therapy. 26 Therefore, elimination of immunologic rejection or induction of immunologic tolerance of the transplanted stem cells or their derivatives is a critical issue in stem cell-based medicine. 27 In the present study, we used tacrolimus as the only immunosuppressant in a xenotransplantation model; therefore, the failure of prolonged engraftment of hiPS-CMs could have been due to insufficient immunosuppressive therapy. A previous study has demonstrated that combined therapy with tacrolimus and sirolimus significantly prolonged the survival of human ES cells in a xenotransplantation model. 28 In another experiment, blocking the leukocyte costimulatory molecules was found to promote successful engraftment of ES and iPS cells in allogeneic and xenogeneic transplantation models. 26 These findings indicate that appropriate immunosuppressive therapies could improve stem cell engraftment. However, the immunogenicity of iPS cells has not yet been fully investigated. Further studies are needed to establish appropriate strategies for inducing and maintaining immunologic tolerance during the clinical use of allogeneic iPS cell therapy.
In conclusion, the present study showed that our culture system yields a large number of highly pure hiPS-CMs and that hiPS-CM sheets could improve cardiac function in the context of ischemic cardiomyopathy, primarily through paracrine cytokine effects. This newly developed culture system and the hiPS-CM sheets may provide a basis for clinical hiPS-CM-sheet transplantation as part of a strategy for promoting the regeneration of damaged myocardium. red (B) . E-G, Detection of hiPS-CMs 8 weeks after transplantation by fluorescence in situ hybridization (FISH) using a human-specific genomic probe; immunostaining for sMHC is shown in green (E) and positive FISH signals in red (F). The nuclei were stained with DAPI in blue (C, E, F) . Merged images are shown in D and G. Barϭ10 m in D and G. hiPS-CM indicates human induced pluripotent stem cell-derived cardiomyocyte; DAPI, 4Ј,6-diamidino-2-phenylindole dihydrochloride.
